More tools:Markets·Screener·Research·Chat

Pulse Biosciences, Inc Common Stock (DE) (PLSE) Financial Statements

Pulse Biosciences, Inc Common Stock (DE)
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG00BRBHVG7
XNAS · usd
48.79▼ 4.45 (-8.36%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close53.24
Day's Range47.70 – 53.11
52-Week Range12.56 – 55.37
Volume768.8K
Avg Volume502.0K
Share Statistics
Shares Outstanding
Employees116
ExchangeXNAS
Listed2016-05-18
Share count as of July 31, 2026
Loading Income Statement…
Key questions about Pulse Biosciences, Inc Common Stock (DE) (PLSE)
What is Pulse Biosciences, Inc Common Stock (DE)'s Market Cap?
Pulse Biosciences, Inc Common Stock (DE)'s Market Cap is $3.5B, based on as-reported figures from SEC (XBRL) filings.
What is Pulse Biosciences, Inc Common Stock (DE)'s Enterprise Value?
Pulse Biosciences, Inc Common Stock (DE)'s Enterprise Value is $3.4B, based on as-reported figures from SEC (XBRL) filings.
What is Pulse Biosciences, Inc Common Stock (DE)'s Price / Sales?
Pulse Biosciences, Inc Common Stock (DE)'s Price / Sales is 2936.6×, based on as-reported figures from SEC (XBRL) filings.
What is Pulse Biosciences, Inc Common Stock (DE)'s EV / Revenue?
Pulse Biosciences, Inc Common Stock (DE)'s EV / Revenue is 2850.8×, based on as-reported figures from SEC (XBRL) filings.
What is Pulse Biosciences, Inc Common Stock (DE)'s EV / EBITDA?
Pulse Biosciences, Inc Common Stock (DE)'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Pulse Biosciences, Inc Common Stock (DE)'s Revenue (TTM)?
Pulse Biosciences, Inc Common Stock (DE)'s Revenue (TTM) is $1.2M, based on as-reported figures from SEC (XBRL) filings.
What is Pulse Biosciences, Inc Common Stock (DE)'s Net Income (TTM)?
Pulse Biosciences, Inc Common Stock (DE)'s Net Income (TTM) is -$80.1M, based on as-reported figures from SEC (XBRL) filings.
What is Pulse Biosciences, Inc Common Stock (DE)'s EBITDA?
Pulse Biosciences, Inc Common Stock (DE)'s EBITDA is -$82.0M, based on as-reported figures from SEC (XBRL) filings.
What is Pulse Biosciences, Inc Common Stock (DE)'s Diluted EPS (TTM)?
Pulse Biosciences, Inc Common Stock (DE)'s Diluted EPS (TTM) is -1.12, based on as-reported figures from SEC (XBRL) filings.
What is Pulse Biosciences, Inc Common Stock (DE)'s EBITDA Margin?
Pulse Biosciences, Inc Common Stock (DE)'s EBITDA Margin is -6921.4%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Product revenue
YoY growth————
Cost and expenses:
Cost of product revenue
Research and development
Selling, general and administrative
Total cost and expenses
% of revenue5923.0%4875.6%7014.0%23782.6%
Loss from operations
% of revenue-5823.0%-4775.6%-6914.0%-23682.6%
Other income (expense):
Interest income
Other income (expense)
Total other income
Net loss
% of revenue-5681.3%-4633.7%-6603.4%-22540.7%
Net loss per share, basic and diluted (in dollars per share)